Phase I clinical trial of the glutamine antagonist DON (NSC 7365) on a 5-day schedule

R. H. Earhart, J. M. Koeller, H. L. Davis

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationProceedings of the American Association for Cancer Research
Pages756
Number of pages1
VolumeVol. 22
StatePublished - 1981
Externally publishedYes

Fingerprint

Clinical Trials, Phase I
Glutamine
Appointments and Schedules

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Earhart, R. H., Koeller, J. M., & Davis, H. L. (1981). Phase I clinical trial of the glutamine antagonist DON (NSC 7365) on a 5-day schedule. In Proceedings of the American Association for Cancer Research (Vol. Vol. 22, pp. 756)

Phase I clinical trial of the glutamine antagonist DON (NSC 7365) on a 5-day schedule. / Earhart, R. H.; Koeller, J. M.; Davis, H. L.

Proceedings of the American Association for Cancer Research. Vol. Vol. 22 1981. p. 756.

Research output: Chapter in Book/Report/Conference proceedingChapter

Earhart, RH, Koeller, JM & Davis, HL 1981, Phase I clinical trial of the glutamine antagonist DON (NSC 7365) on a 5-day schedule. in Proceedings of the American Association for Cancer Research. vol. Vol. 22, pp. 756.
Earhart RH, Koeller JM, Davis HL. Phase I clinical trial of the glutamine antagonist DON (NSC 7365) on a 5-day schedule. In Proceedings of the American Association for Cancer Research. Vol. Vol. 22. 1981. p. 756
Earhart, R. H. ; Koeller, J. M. ; Davis, H. L. / Phase I clinical trial of the glutamine antagonist DON (NSC 7365) on a 5-day schedule. Proceedings of the American Association for Cancer Research. Vol. Vol. 22 1981. pp. 756
@inbook{5b8c31783f764bd0b7adb3d185fc754a,
title = "Phase I clinical trial of the glutamine antagonist DON (NSC 7365) on a 5-day schedule",
author = "Earhart, {R. H.} and Koeller, {J. M.} and Davis, {H. L.}",
year = "1981",
language = "English (US)",
volume = "Vol. 22",
pages = "756",
booktitle = "Proceedings of the American Association for Cancer Research",

}

TY - CHAP

T1 - Phase I clinical trial of the glutamine antagonist DON (NSC 7365) on a 5-day schedule

AU - Earhart, R. H.

AU - Koeller, J. M.

AU - Davis, H. L.

PY - 1981

Y1 - 1981

UR - http://www.scopus.com/inward/record.url?scp=0019424815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019424815&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:0019424815

VL - Vol. 22

SP - 756

BT - Proceedings of the American Association for Cancer Research

ER -